Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Yoichi Kakuta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Osaka Graduate School of Medicine, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Graft Rejection, Isoantibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
This study investigated the impact of immunosuppressive drug concentrations on microvascular inflammation (MVI) in kidney transplant recipients with negative donor‐specific antibodies (DSA) against human leukocyte antigen (HLA) and negative C4d deposition in peritubular capillaries.
Methods
We analyzed data from 268 living kidney transplant recipients at the Department of Urology, University of Osaka, Japan. Patients received immunosuppressive therapy comprising extended‐release tacrolimus, mycophenolate mofetil (MMF), and/or everolimus, with or without steroids. Graft biopsies were routinely performed at 3, 12, 36 and 60 months post‐surgery.
Results
No significant differences were observed between the MVI+DSA‐C4d‐ and MVI‐DSAC4d groups regarding graft survival rates (95.5% vs. 96.6%, p = 0.772) or patient survival rates (95.7% vs. 95.9%, p = 0.735). Lower tacrolimus and everolimus concentrations were significantly associated with an increased risk of MVI+DSA‐C4d‐ (tacrolimus: OR, 0.169; 95% CI, 0.055–0.515; p = 0.002; everolimus: OR, 0.386; 95% CI, 0.171–0.874; p = 0.022). In contrast, MPA concentration was not significantly associated with MVI+DSA‐C4d‐ (OR, 0.994; 95% CI, 0.554–1.780; p = 0.984). Steroid discontinuation did not significantly impact the risk of MVI+DSA‐C4d‐ (OR, 1.980; 95% CI, 0.318–12.000; p = 0.470).
Conclusion
Lower trough levels of tacrolimus and everolimus correlated with a higher incidence of antibody‐independent MVI, supporting the need for tailored immunosuppressive regimens in kidney transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Osaka Graduate School of Medicine, Suita, Osaka, Japan.
- Department of Nephrology, Osaka Graduate School of Medicine, Suita, Osaka, Japan.
ORCID-Profile: Yoichi Kakuta, Ryo Tanaka
Zitieren
APA
Kakuta, Y., Maegawa-Higa, Y., Matsumura, S., Fukae, S., Tanaka, R., Yonishi, H., Nakazawa, S., Namba-Hamano, T., Isaka, Y., & Nonomura, N. (2025). Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70112
Vancouver
Kakuta Y, Maegawa-Higa Y, Matsumura S, Fukae S, Tanaka R, Yonishi H, et al. Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients. Clinical Transplantation. 2025. doi:10.1111/ctr.70112
BibTeX
@article{Kakuta2025,
author = {Kakuta, Yoichi and Maegawa-Higa, Yoko and Matsumura, Soichi and Fukae, Shota and Tanaka, Ryo and Yonishi, Hiroaki and Nakazawa, Shigeaki and Namba-Hamano, Tomoko and Isaka, Yoshitaka and Nonomura, Norio},
title = {Impact of Immunosuppressive Drug Concentrations on Microvascular Inflammation, Negative Donor‐Specific Antibodies, and C4d‐Negative Status in Kidney Transplant Recipients},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70112}
}
EUVIMED